Clinical implications of food–drug interactions with small-molecule kinase inhibitors

GDM Veerman, KGAM Hussaarts… - The Lancet …, 2020 - thelancet.com
During the past two decades, small-molecule kinase inhibitors have proven to be valuable in
the treatment of solid and haematological tumours. However, because of their oral …

Erlotinib

AA Abdelgalil, HM Al-Kahtani, FI Al-Jenoobi - Profiles of Drug Substances …, 2020 - Elsevier
Abstract Erlotinib (OSI-774), marketed by Genentech as Tarceva®, is anticancer drug
approved by US-FDA for the treatment of Non-Small Cell Lung Cancer (NSCLC) and …

[HTML][HTML] The influence of green tea extract on nintedanib's bioavailability in patients with pulmonary fibrosis

GDM Veerman, SC van der Werff, SLW Koolen… - Biomedicine & …, 2022 - Elsevier
Nintedanib is an oral small-molecule kinase inhibitor and first-line treatment for idiopathic
pulmonary fibrosis. Nintedanib is a substrate of the drug efflux transporter ABCB1. Green tea …

Changing Trends Towards Herbal Supplements: An Insight into Safety and Herb-drug Interaction

H Rasheed, S Ahmed, A Sharma - Current Pharmaceutical …, 2024 - ingentaconnect.com
Herbs have been used as sustenance and medicine for a very long time, often in
conjunction with other prescribed medications. Even though they are thought to be natural …

[HTML][HTML] The role of ethnicity in personalized dosing of small molecule tyrosine kinase inhibitors used in oncology

JA Touma, AJ McLachlan… - Translational Cancer …, 2017 - tcr.amegroups.org
Inter-ethnic differences in systemic exposure, efficacy and safety have been reported for
some small molecule tyrosine kinase inhibitors (smTKIs). This variability in response related …

[HTML][HTML] Tea consumption and risk of lung diseases: a two‑sample Mendelian randomization study

L Chen, Y Deng, T Wang, X Lin, L Zheng… - BMC Pulmonary …, 2023 - Springer
Background Numerous studies have reported the association between tea intake and lung
diseases. However, the probable relationship between tea consumption on lung diseases …

[HTML][HTML] Rapid screening of ellagitannins in natural sources via targeted reporter ion triggered tandem mass spectrometry

JJ Bowers, HP Gunawardena, A Cornu, AS Narvekar… - Scientific reports, 2018 - nature.com
Complex biomolecules present in their natural sources have been difficult to analyze using
traditional analytical approaches. Ultrahigh-performance liquid chromatography (UHPLC …

Rapid high performance liquid chromatography method for erlotinib quantification in vitro: Application to study the effect of resveratrol on metabolism and cellular …

A Zayed, J Al Hroot, A Mayyas… - Fundamental & Clinical …, 2023 - Wiley Online Library
Background: Erlotinib is a selective epidermal growth factor receptor inhibitor that is used for
the treatment of non‐small cell lung cancer and pancreatic cancer. Its metabolism is mainly …

[HTML][HTML] Pharmacokinetics of Quercetin-Loaded Methoxy Poly (ethylene glycol)-b-poly (L-lactic acid) Micelle after Oral Administration in Rats

L Lv, C Liu, Z Li, F Song, G Li, X Huang - BioMed Research …, 2017 - hindawi.com
The purpose of this study was to evaluate the potential of micelle to change the
pharmacokinetics of quercetin (QUT), with a primary goal of enhancing its oral …

[HTML][HTML] The risk of QTc-interval prolongation in breast cancer patients treated with tamoxifen in combination with serotonin reuptake inhibitors

KGAM Hussaarts, FA Berger, L Binkhorst… - Pharmaceutical …, 2020 - Springer
Purpose Antidepressants like the serotonin reuptake inhibitors (SRIs) are often used
concomitantly with tamoxifen (eg for treatment of depression). This may lead to an additional …